Log In
Print this Print this

PredictMDx for Colon Cancer

  Manage Alerts
Collapse Summary General Information
Company MDxHealth S.A.
DescriptionDiagnostic test for predicting patient response to alkylating agents
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentDiscovery
Standard IndicationCancer, Diagnostic
Indication DetailsPredict likelihood of benefit from the use of irinotecan based chemotherapy
Regulatory Designation
PartnerPlus Diagnostics

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today